Total Payments
$39,185
2024 Payments
$10,468
Companies
84
Transactions
1,186
Medicare Patients
9,615
Medicare Billing
$3.9M
Payment Breakdown by Category
Food & Beverage$23,908 (61.0%)
Consulting$12,974 (33.1%)
Other$1,540 (3.9%)
Education$762.42 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,908 | 1,137 | 61.0% |
| Consulting Fee | $12,974 | 10 | 33.1% |
| Long term medical supply or device loan | $1,165 | 13 | 3.0% |
| Education | $762.42 | 24 | 1.9% |
| Honoraria | $375.00 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,427 | 87 | $0 (2024) |
| PFIZER INC. | $3,874 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,760 | 105 | $0 (2024) |
| EMD Serono, Inc. | $3,041 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,384 | 46 | $0 (2024) |
| Celgene Corporation | $1,630 | 81 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $1,610 | 6 | $0 (2023) |
| SEAGEN INC. | $1,425 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $1,401 | 48 | $0 (2024) |
| Lilly USA, LLC | $1,280 | 58 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,468 | 294 | PFIZER INC. ($3,281) |
| 2023 | $6,622 | 311 | Novartis Pharmaceuticals Corporation ($571.74) |
| 2022 | $7,719 | 231 | E.R. Squibb & Sons, L.L.C. ($1,686) |
| 2021 | $10,595 | 211 | EMD Serono, Inc. ($2,711) |
| 2020 | $1,978 | 89 | AstraZeneca Pharmaceuticals LP ($361.73) |
| 2019 | $788.84 | 39 | Genentech USA, Inc. ($213.94) |
| 2018 | $280.07 | 4 | Seattle Genetics, Inc. ($248.12) |
| 2017 | $734.01 | 7 | Genentech USA, Inc. ($250.08) |
All Payment Transactions
1,186 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | PADCEV (Biological) | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| Category: Oncology | ||||||
| 12/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug), Odomzo | Food and Beverage | In-kind items and services | $41.84 | General |
| Category: Oncology | ||||||
| 12/30/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: Hematology | ||||||
| 12/16/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $25.17 | General |
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Fennec Pharmaceuticals, Inc. | Pedmark (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Cisplatin-induced Ototoxicity | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.85 | General |
| Category: Hematology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Oncology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Oncology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.42 | General |
| 11/25/2024 | SEAGEN INC. | — | Education | In-kind items and services | $98.65 | General |
| 11/22/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: Hematology | ||||||
| 11/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| Category: Hematology | ||||||
| 11/19/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $97.15 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 2,780 | 92,596 | $3.9M | $1.0M |
| 2022 | 49 | 3,251 | 184,141 | $7.0M | $1.8M |
| 2021 | 31 | 1,872 | 126,828 | $2.3M | $606,757 |
| 2020 | 27 | 1,712 | 121,998 | $1.6M | $432,787 |
Total Patients
9,615
Total Services
525,563
Medicare Billing
$3.9M
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 40 | 13,260 | $908,100 | $244,674 | 26.9% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 84 | 9,900 | $678,600 | $164,859 | 24.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 87 | 125 | $574,701 | $147,649 | 25.7% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 37 | 13,880 | $346,990 | $80,407 | 23.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 66 | 686 | $262,988 | $66,568 | 25.3% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 27 | 7,461 | $179,504 | $47,776 | 26.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 83 | 117 | $179,361 | $46,873 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 504 | $135,801 | $32,283 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 294 | $112,526 | $26,362 | 23.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 69 | 772 | $65,523 | $16,851 | 25.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 315 | 1,929 | $44,367 | $14,666 | 33.1% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 11 | 91 | $14,454 | $11,330 | 78.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 289 | 1,230 | $29,855 | $10,315 | 34.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 119 | 916 | $38,472 | $9,503 | 24.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 108 | 198 | $37,103 | $9,168 | 24.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 26 | 148 | $31,428 | $7,960 | 25.3% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 26 | 160 | $30,224 | $7,714 | 25.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 236 | 701 | $22,432 | $7,255 | 32.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 57 | 602 | $27,366 | $7,081 | 25.9% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 13 | 14,790 | $31,110 | $5,608 | 18.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $21,170 | $5,524 | 26.1% |
| J0640 | Injection, leucovorin calcium, per 50 mg | Office | 2023 | 14 | 1,537 | $16,907 | $4,817 | 28.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 159 | 351 | $14,391 | $4,689 | 32.6% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2023 | 46 | 115 | $7,130 | $2,345 | 32.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 21 | 105 | $8,691 | $2,155 | 24.8% |
About Dr. Aaron Denson, M.D
Dr. Aaron Denson, M.D is a Internal Medicine healthcare provider based in Brooksville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1861735888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Denson, M.D has received a total of $39,185 in payments from pharmaceutical and medical device companies, with $10,468 received in 2024. These payments were reported across 1,186 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($23,908).
As a Medicare-enrolled provider, Denson has provided services to 9,615 Medicare beneficiaries, totaling 525,563 services with total Medicare billing of $3.9M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Brooksville, FL
- Active Since 03/27/2013
- Last Updated 06/08/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861735888
Products in Payments
- PADCEV (Biological) $3,761
- KISQALI (Drug) $2,329
- Bavencio (Drug) $2,182
- IMFINZI (Biological) $2,070
- REBLOZYL (Biological) $1,614
- VYXEOS (Drug) $1,500
- KEYTRUDA (Biological) $1,036
- CALQUENCE (Drug) $822.42
- Lenvima (Drug) $750.43
- LYNPARZA (Drug) $658.53
- OPDIVO (Biological) $559.13
- XOSPATA (Drug) $555.44
- Trodelvy (Drug) $552.70
- VERZENIO (Drug) $509.50
- IMBRUVICA (Drug) $501.08
- Tepmetko (Drug) $500.00
- Nubeqa (Drug) $458.50
- ADCETRIS (Biological) $432.19
- Enhertu (Drug) $378.92
- MEKINIST (Drug) $355.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooksville
Dr. Muhammed-Rodwan Hiba, Md, MD
Internal Medicine — Payments: $14,108
Internal Medicine $14,108
Dr. Frantz Francisque
Internal Medicine — Payments: $11,943
Internal Medicine $11,943
Tanveer Chaudhry, Md, MD
Internal Medicine — Payments: $9,815
Internal Medicine $9,815
Mr. David Moreno, M.d, M.D
Internal Medicine — Payments: $5,256
Internal Medicine $5,256
Rami Abboud, Md, MD
Internal Medicine — Payments: $4,060
Internal Medicine $4,060
Mahmoud Nimer, M.d, M.D
Internal Medicine — Payments: $3,391
Internal Medicine $3,391